Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

FOXO4-DRI vs FOXO4: The Critical Structural Difference

FOXO4 is the endogenous transcription factor. A 505-amino-acid protein that regulates oxidative stress response, glucose metabolism, and cell cycle arrest in response to DNA damage. FOXO4-DRI is a 29-amino-acid synthetic peptide fragment that retains only the

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • FOXO4 is the endogenous transcription factor. A 505-amino-acid protein that regulates oxidative stress response, glucose metabolism, and cell cycle arrest in response to DNA damage. FOXO4-DRI is a 29-amino-acid synthetic peptide fragment that retains only the p53-binding domain of the full-length FOXO4 protein, reengineered with D-amino acids (mirror-image forms resistant to protease degradation) arranged in reverse sequence. This D-retro-inverso modification gives FOXO4-DRI a half-life measured in hours rather than minutes, allowing sustained disruption of the FOXO4-p53 complex that keeps senescent cells alive.
  • The naming confusion stems from the fact that 'FOXO4-DRI' and 'FOXO4 DRI' refer to the same peptide. Researchers use both interchangeably in literature, though the hyphenated form (FOXO4-DRI) is more common in formal publications. The mechanism is identical: competitive inhibition of the endogenous FOXO4-p53 interaction. When FOXO4-DRI enters a senescent cell, it binds p53 more aggressively than the native FOXO4 protein can, displacing FOXO4 and freeing p53 to activate apoptotic pathways that would normally be silenced in these cells.
  • Healthy proliferating cells tolerate FOXO4-DRI exposure without triggering apoptosis because they don't rely on the FOXO4-p53 interaction for survival. Senescent cells do. Senescent cells accumulate p53 at levels 3–5 times higher than normal cells and depend on FOXO4 to sequester p53 in the cytoplasm, preventing nuclear translocation that would trigger cell death. FOXO4-DRI breaks that dependency, and within 24–48 hours, senescent cells undergo programmed cell death while surrounding healthy tissue remains unaffected.